Brief: Shenzhen Neptunus Interlong Bio-Technique entered into Neptunus Group Sales Framework Agreement
30/06/2017 15:13
June 30 (Reuters) - Shenzhen Neptunus Interlong
Bio-technique Co Ltd 8329.HK
* Company entered into neptunus group sales framework
agreement with shenzhen neptunus group company limited
* Agreed to sell self-manufactured or distributed products
to neptunus group
* Neptunus changjian and jiamusi neptunus mutually agreed to
terminate pharmaceutical product framework agreement
Source text for Eikon: ID:nHKS3CNPT1
Further company coverage: 8329.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Shenzhen Neptunus Interlong Bio-technique
See all newsBrief: Shenzhen Neptunus Interlong Bio-Technique's Unit Enters Into JV Agreement With Huikang Bio-Technology
China's Neptunus Interlong H1 revenue falls
Brief: Shenzhen Neptunus Interlong Bio-Technique Expects Net Profit Attributable To Owners Of RMB 7 Million For 2026 Interim Period
Brief: Shenzhen Neptunus Interlong Bio-Technique Posts FY Loss & Total Comprehensive Expenses Attributable RMB40.7 Million
Brief: Shenzhen Neptunus Interlong Bio-Technique Sees FY Net Loss Attributable Of RMB40 Million